PT-141 10mg
PT-141 is supplied at 10mg as a lyophilised powder for laboratory research use only. Orders are dispatched from Australia, typically within 3 to 7 business days of order, depending on your state, and we email your tracking details when your order is dispatched.
Specifications
- Product: PT-141 (bremelanotide, cyclic heptapeptide melanocortin receptor agonist)
- Strength: 10mg
- Format: lyophilised powder
- Storage: 2-8°C
- Documentation: certificate of analysis available on request by email to customerservice@genesispeptidesau.com
- Intended use: laboratory research only
Research context
PT-141 (also known as bremelanotide) is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone that acts as an agonist at melanocortin receptors. Pfaus and colleagues (2004) used a melanocortin receptor agonist of this class in rat studies to examine the involvement of melanocortin receptors in behaviour in that animal model. In laboratory work it is used as a reference agonist in melanocortin receptor binding and signalling assays. Published findings describe receptor pharmacology and experimental systems only and are not evidence of effects in people. Researchers should follow their own validated protocol for solvent choice, assay conditions and handling, and review the batch certificate of analysis before use.
Reference:
1. Pfaus J et al. Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist. Proc Natl Acad Sci USA. 2004;101:10201-10204.
Handling and storage
Request the certificate of analysis for your batch by email to customerservice@genesispeptidesau.com before use and check it against the label. Store sealed at 2-8°C. Follow the storage guidance on the batch document if it differs.
Compliance notice
For laboratory research use only. Not for human or veterinary use, and not a medicine, supplement, food or cosmetic. Nothing on this page is advice on use, dosing or treatment.














